Research
Fully understanding Long COVID requires a comprehensive, multi-disciplinary approach, and strong public and private partnerships. HHS and federal partners are funding and conducting research to better understand Long COVID. The National Research Action Plan on Long COVID provides the first U.S. government-wide national research agenda for Long COVID. It also details Long COVID research funded or conducted by the federal government.
The U.S. government research portfolio spans seven areas.
- Characterizing the full clinical spectrum of long COVID and diagnostic strategies
- Pathophysiology
- Surveillance and epidemiology
- Wellbeing
- Therapeutics and other interventions
- Human services, supports, and interventions
- Health services and health economics research
For information about specific studies please visit the sites below
Centers for Disease Control and Prevention Long COVID Science
National Institutes of Health RECOVER Initiative
Department of Veterans Affairs is conducting numerous research studies
Clinical Trials
Clinical trials are medical research studies with volunteers. The goal is to determine whether a new treatment or vaccine works and is safe for people to use. After researchers thoroughly test new treatments or vaccines in the lab to make sure they may benefit people, the most promising treatments move into clinical trials.
NIH’s RECOVER initiative, the US Department of Veterans Affairs, and the Department of Defense are hosting clinical trials for Long COVID.
You can search for clinical trials on Long COVID at clinicaltrials.gov.
Surveys
To support the development of services, supports and interventions for Long COVID and its associated conditions data collection is important.
National surveys that may provide data on Long COVID are listed below.
Behavioral Risk Factor Surveillance System
Medicare Current Beneficiary Survey
National Survey of Children’s Health
National Survey on Health and Disability